225 pipelines of biologics being developed in Korea
There were reportedly 225 cases of clinical trials for biologics being developed in Korea.
According to the Ministry of Food and Drug Safety(MFDS), there were ongoing clinical trials for total 225 products at the end of 2016: 151 generic recombinant medicines, 33 cell therapies, 32 biologics and...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
